RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $884K of Relay Therapeutics, Inc.
Sold$883,680
$21.04Price
42,000Shares
−3%Stake
What RLAY did after the filing
- The stock from Thu, Oct 13 close, $20.48
- −9.1%
- S&P 500, same days
- +9.9%
Measured over 30 trading days, to the Nov 25 close.
Traded Tue, Oct 11. Filed Thu, Oct 13, 2:09 PM ET, during the session. Returns use the Oct 13 close and the Nov 25 close. Not investment advice.